They are not a substitute for methotrexate, and they are not a substitute for a TNF inhibitor or any other biologic
Reports and Surveys | January 22, 2026 We conducted a cost-benefit analysis of glucagon-like peptide-1 agonists (GLP-1s) using data from SHAPE, our proprietary health data warehouse
(PubMed) Lopez-Sobaler AM, Ortega RM, Quintas ME, et al
Pharmacological inhibition of GLS via CB-839 or BPTES amplifies PCa cell sensitivity to metformin ( 4.3.7 Limitations of drugs targeting ammonium metabolism Although systematic investigations into the adverse effects of ammonium metabolism-targeting agents in prostate cancer remain limited, their toxicological profiles have been relatively well characterized in other solid tumors, such as breast, pancreatic, and gastrointestinal cancers (211, 222, 238)
Cox DJ, Gonder-Frederick L, Ritterband L et al (2006) Blood glucose awareness training: what is it, where is it, and where is it going
Many clinics provide certificates of analysis showing purity testing results, typically demonstrating 98%+ purity levels for peptides like semaglutide and tirzepatide